Cargando…

Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy

BACKGROUND: Cancer cachexia (CCx) is a multifactorial wasting disorder characterized by involuntary loss of body weight that affects many cancer patients and implies a poor prognosis, reducing both tolerance to and efficiency of anticancer therapies. Actual challenges in management of CCx remain in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morigny, Pauline, Kaltenecker, Doris, Zuber, Julia, Machado, Juliano, Mehr, Lisa, Tsokanos, Foivos‐Filippos, Kuzi, Hanna, Hermann, Chris D., Voelkl, Michael, Monogarov, German, Springfeld, Christoph, Laurent, Victor, Engelmann, Bernd, Friess, Helmut, Zörnig, Inka, Krüger, Achim, Krijgsveld, Jeroen, Prokopchuk, Olga, Fisker Schmidt, Søren, Rohm, Maria, Herzig, Stephan, Berriel Diaz, Mauricio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517355/ https://www.ncbi.nlm.nih.gov/pubmed/34427055 http://dx.doi.org/10.1002/jcsm.12758

Ejemplares similares

High levels of modified ceramides are a defining feature of murine and human cancer cachexia
por: Morigny, Pauline, et al.
Publicado: (2020)

Aging Aggravates Cachexia in Tumor-Bearing Mice
por: Geppert, Julia, et al.
Publicado: (2021)

Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status
por: Chovsepian, Alexandra, et al.
Publicado: (2023)

Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism
por: Hartleben, Goetz, et al.
Publicado: (2021)

MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
por: Patzelt, Lisa, et al.
Publicado: (2021)

A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
por: Prokopchuk, Olga, et al.
Publicado: (2021)

The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
por: Schwarz, S., et al.
Publicado: (2017)

Imaging modalities for diagnosis and monitoring of cancer cachexia
por: Han, Jessie, et al.
Publicado: (2021)

eIF4A inactivates TORC1 in response to amino acid starvation
por: Tsokanos, Foivos‐Filippos, et al.
Publicado: (2016)

Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
por: Mueller, Tara C., et al.
Publicado: (2016)

Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
por: Prokopchuk, Olga, et al.
Publicado: (2018)

Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
por: Schäfer, Michaela, et al.
Publicado: (2015)

Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases
por: Pellegata, Natalia S., et al.
Publicado: (2022)

Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)

‘Corrigendum to “Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia” [Molecular Metabolism 5 (2) (2015) 67–78]’
por: Schäfer, Michaela, et al.
Publicado: (2020)

Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
por: Zhang, Juan, et al.
Publicado: (2016)

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2021)

The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism
por: Oh, Mihee, et al.
Publicado: (2023)

Fasting‐sensitive SUMO‐switch on Prox1 controls hepatic cholesterol metabolism
por: Alfaro, Ana Jimena, et al.
Publicado: (2023)

Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia
por: Taylor, Jacqueline, et al.
Publicado: (2023)

Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control
por: Bühler, Lea, et al.
Publicado: (2021)

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A(2) Activity: A Randomized, Controlled Trial
por: Johnson, Joel L., et al.
Publicado: (2014)

Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A(2) by detergent micelles or lipoproteins and for the efficacy reduction of darapladib
por: Zhuo, Shaoqiu, et al.
Publicado: (2020)

Specific miRNAs are associated with human cancer cachexia in an organ‐specific manner
por: Krauss, Tanja, et al.
Publicado: (2023)

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib
por: Yeo, Astrid, et al.
Publicado: (2017)

Lp-PLA(2) Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus
por: Wihastuti, Titin Andri, et al.
Publicado: (2019)

Multiple intestinal intussusceptions caused by highly impaired gastrointestinal motility in a patient with chronic cannabis consumption
por: Prokopchuk, Olga, et al.
Publicado: (2019)

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Held, Claes, et al.
Publicado: (2017)

Maffucci syndrome and neoplasms: a case report and review of the literature
por: Prokopchuk, Olga, et al.
Publicado: (2016)

Measurement of body mass by bioelectrical impedance analysis and computed tomography in cancer patients with malnutrition – a cross-sectional observational study
por: Mueller, Tara Catharina, et al.
Publicado: (2020)

Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function
por: Bachmann, Jeannine, et al.
Publicado: (2009)

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Guimarães, Patricia Oliveira, et al.
Publicado: (2017)

Purification of GFP-tagged nuclei from frozen livers of INTACT mice for RNA- and ATAC-sequencing
por: Loft, Anne, et al.
Publicado: (2021)

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A(2) Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial
por: Hu, Chaoying, et al.
Publicado: (2015)

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
por: Fanola, Christina L., et al.
Publicado: (2017)

Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial
por: Eisen, Alon, et al.
Publicado: (2017)

Cancer cachexia.
por: Tisdale, M. J.
Publicado: (1991)

Cancer cachexia
por: Dhanapal, Raghu, et al.
Publicado: (2011)

Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3pq8uh6kktjt2srfue6bu4airh